Alanazi, Ashwag S., James, Edward and Mehellou, Youcef ORCID: https://orcid.org/0000-0001-5720-8513 2019. The protide prodrug technology: Where next? ACS Medicinal Chemistry Letters 10 (1) , pp. 2-5. 10.1021/acsmedchemlett.8b00586 |
Preview |
PDF
- Accepted Post-Print Version
Download (5MB) | Preview |
Official URL: http://dx.doi.org/10.1021/acsmedchemlett.8b00586
Abstract
The ProTide prodrug technology has proved very useful in the discovery of nucleotide therapeutics and has successfully led to two FDA-approved drugs. However, with the extensive application of this prodrug approach to nucleotides for nearly three decades, the intellectual property (IP) landscape is becoming congested and, to overcome this, new inventive applications of the ProTide prodrug technology are emerging.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Pharmacy |
Publisher: | American Chemical Society |
ISSN: | 1948-5875 |
Date of First Compliant Deposit: | 2 January 2019 |
Date of Acceptance: | 15 December 2018 |
Last Modified: | 15 Nov 2024 16:45 |
URI: | https://orca.cardiff.ac.uk/id/eprint/117958 |
Citation Data
Cited 30 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |